The efferent ductules express the highest amount of estrogen receptors ESR1 (ERalpha) and ESR2 (ERbeta) within the male reproductive tract. Treatment of rats with the antiestrogen fulvestrant (ICI 182,780) causes inhibition of fluid reabsorption in the efferent ductules, leading to seminiferous tubule atrophy and infertility. To provide a more comprehensive knowledge about the molecular targets for estrogen in the rat efferent ductules, we investigated the effects of ICI 182,780 treatment on gene expression using a microarray approach. Treatment with ICI 182,780 increased or reduced at least 2-fold the expression of 263 and 98 genes, respectively. Not surprisingly, several genes that encode ion channels and macromolecule transporters were affected. Interestingly, treatment with ICI 182,780 markedly altered the expression of genes related to extracellular matrix organization. Matrix metalloproteinase 7 (Mmp7), osteopontin (Spp1), and neuronal pentraxin 1 (Nptx1) were among the most altered genes in this category. Upregulation of Mmp7 and Spp1 and downregulation of Nptx1 were validated by Northern blot. Increase in Mmp7 expression was further confirmed by immunohistochemistry and probably accounted for the decrease in collagen content observed in the efferent ductules of ICI 182,780-treated animals. Downregulation of Nptx1 probably contributed to the extracellular matrix changes and decreased amyloid deposition in the efferent ductules of ICI 182,780-treated animals. Identification of new molecular targets for estrogen action may help elucidate the regulatory role of this hormone in the male reproductive tract.
INTRODUCTION
It is now well established that estrogen plays an important role in male reproductive function (reviewed in Hess et al. [1] and Hess and Carnes [2] ). In the male reproductive tract, estrogen is mainly synthesized by Sertoli, Leydig, and germ cells, which contain the aromatase cytochrome P450 that catalyzes the conversion of testosterone to estradiol (reviewed in Simpson and Davis [3] and Carreau et al. [4, 5] ). Recent studies have demonstrated the presence of aromatase also in human and rat epididymis and in human efferent ductules [6, 7] . The main evidence for the essential role of estrogen in the control of male reproductive function came from the demonstration that male fertility is impaired in mice with a knockout of the estrogen receptor ESR1 (Esr1 ) genes. Esr1 À/À animals are infertile due to a defect in the development and function of the efferent ductules [8] [9] [10] [11] , whereas infertility in Cyp19 À/À animals is mainly caused by a defect of the germ cell function [12] .
The efferent ductules constitute a conduit for the passage of fluids and spermatozoa from the testis to the epididymis, and their primary function is to reabsorb more than 90% of the testicular fluid, concentrating luminal sperm prior to entry into the epididymis [13, 14] . The efferent ductules across all species express the highest concentration of estrogen receptors ESR1 and ESR2 within the male reproductive tract [2, [15] [16] [17] [18] , and the most severe histopathological changes after disruption of ESR1 occur in this organ [1, 10, 19, 20] . The lack of ESR1 severely impairs the absorptive function of the efferent ductules, causing fluid accumulation and luminal dilation. In rats, treatment with fulvestrant (ICI 182,780), a steroidal antiestrogen that impairs estrogen action on both ESR1 and ESR2 [21] and does not cross the blood-brain barrier [22] , causes morphological and functional changes in the efferent ductules similar to those seen in the Esr1 À/À mice, including luminal dilation and reduction of the epithelial height, that ultimately lead to testicular atrophy and infertility [23, 24] . It is important to mention that the effects of ICI 182,780 may differ among species. In mice, long treatment with ICI 182,780 induces the same morphological changes in the efferent ductules but limited and not total atrophy of seminiferous tubules [25] .
The efferent ductules seem, therefore, to be a primary target for estrogen action in the male reproductive tract, but the molecular mechanisms involved are not completely elucidated. Studies on the role of estrogen on gene expression have mainly focused on genes that participate on fluid reabsorption, such as ion transporter molecules. Studies with Esr1 À/À and ICI 182,780-treated mice demonstrated that estrogen regulates the mRNA levels of carbonic anhydrase 2 (Car2), sodium/ hydrogen exchanger 3 (Slc9a3), chloride channel cystic fibrosis transmembrane regulator (Cftr), the solute carrier family 26, member 3, (Slc26a3), and Na þ -K þ -ATPase a1 catalytic subunit [26, 27] . Furthermore, treatment with ICI 182,780 reduced sodium/hydrogen exchanger 3, ESR1, and aquaporin 9 (AQP9), but not ESR2 or androgen receptor (AR) expression in rat efferent ductules [24, 28, 29] .
Considering that estrogen exerts a broad spectrum of effects in several tissues (reviewed in Nilsson et al. [30] , Hewitt et al. [31] , Björnström and Sjöberg [32] , Dahlman-Wright et al. [33] , and Heldring et al. [34] ), it is highly conceivable that estrogen action in efferent ductules is not restricted to the regulation of ion and water transporters, but may also involve other classes of regulatory proteins. The aim of the present study was to perform a more comprehensive analysis of the antiestrogen ICI 182,780 effects on gene expression of the rat efferent ductules using a microarray approach. Identification of new molecular targets for estrogen action may help elucidate its regulatory role in the male reproductive tract.
MATERIALS AND METHODS

Animals and Treatment
Male Wistar rats were born and housed in the Animal Facility at Instituto Nacional de Farmacologia e Biologia Molecular (INFAR), Universidade Federal de São Paulo-Escola Paulista de Medicina (UNIFESP-EPM), and were maintained on a 12L:12D lighting schedule at 238C, with food and water ad libitum. The experimental procedures were conducted according to the guidelines for care and use of laboratory animals, as approved by the Research Ethical Committee from UNIFESP-EPM. Thirty-day-old rats (84.09 6 3.68 g body weight) were treated once a week for 2 mo with soy oil (control group) or ICI 182,780 (10 mg/rat, s.c.; AstraZeneca, São Paulo, Brazil), according to a previously described protocol [24] . The treatment with soy oil did not induce any morphological or functional changes, whereas the treatment with ICI 182,780 was effective to induce alterations in the rat efferent ductules without significant effects on body and sex gland weights.
Determination of Plasma and Tissue Testosterone and Estradiol Levels
Blood samples were collected between 0800 h and 1000 h from the abdominal aorta of control and ICI 182,780-treated animals. Plasma was separated after centrifugation at 1970 3 g for 10 min at room temperature. The efferent ductules were dissected, removed, and immediately frozen in liquid nitrogen. After tissue pulverization, 150 mg of the samples was transferred to glass tubes with 250 ll PBS (137 mM NaCl, 2.68 mM KCl, 8.03 mM Na 2 HPO 4 , 1.46 mM KH 2 PO 4 , pH 7.4) and homogenized at 9500 rpm for 2 min in an Ultra-Turrax homogeneizer. Steroids were extracted twice with 3 ml diethyl ether. After ether evaporation overnight at room temperature, steroids were resuspended in 0.5 ml PBS. Plasma and tissue testosterone levels were determined by solid-phase radioimmunoassay with the Coat-A-Count Total Testosterone kit (Diagnostic Products Co., Los Angeles, CA) according to the instructions of the manufacturer. Results were expressed as nanograms of testosterone per milliliter of plasma or gram of tissue. The detection limit of this assay was 0.04 ng of testosterone per milliliter of sample. For plasma testosterone determination, the intraassay variation was 2.1% to 2.9%, and interassay variation was 4.2% to 5.9%. For tissue testosterone determination, the intraassay variation was 1.2% to 1.7%, and interassay variation was 4.5% to 5.5%. Plasma and tissue estradiol levels were determined by radioimmunoassay with the Double Antibody Estradiol kit (Diagnostic Products Co.), according to the instructions of the manufacturer. The detection limit of this assay was 1.4 pg estradiol per milliliter of sample. For plasma estradiol determination, the intraassay variation was 0.1% to 0.7%, and interassay variation was 0.5% to 1.2%. For tissue estradiol determination, the intraassay variation was 1.1% to 2.0%, and the interassay variation was 4.7% to 6.6%.
RNA Preparation
Total RNA of the efferent ductules from control and ICI 182,780-treated rats was extracted using the RNeasy Mini Kit (QIAgen, Valencia, CA) according to instructions of the manufacturer. RNA was further treated with ribonuclease-free deoxyribonuclease I (QIAgen) to eliminate genomic DNA contamination. RNA concentration was measured by ultraviolet (UV) spectrophotometry, and OD 260:280-nm ratios between 1.8 and 2.1 were obtained for all RNA samples. Ribosomal RNA integrity was checked on agarose gel electrophoresis, and a sharp and clear 2:1 ratio of ethidium bromide-stained 28S:18S ribosomal RNA bands was observed for all samples.
Microarray Studies
Two micrograms of total RNA from each sample was converted into double-stranded cDNA and purified using the Codelink Expression Assay Reagent kit (GE, Piscataway, NJ) and QIAquick PCR Purification kit (QIAgen, Hilden, Germany). The purified cDNA was used for the synthesis of biotinlabeled cRNA, according to the instructions of the manufacturer. Labeled cRNA was then hybridized on a CodeLink Rat Whole Genome Bioarray (GE), which contains 33 849 discovery probes (30 bases in length) representing up to 32 590 unique transcripts. In addition to the discovery probe sequences, each bioarray contains 240 positive and 32 negative bacterial control probes for monitoring array performance. Probe sequences are designed on transcript sequences deposited in the NCBI Unigene build no. 129, the NCBI reference sequence (RefSeq), and dbEST databases. Three independent microarrays (a different RNA sample per slide) per group were performed. The slides were scanned with the Axon GenePix scanner (Arlington, TX) using the software Codelink Expression Scanning (GE), and the initial analysis was performed with the CodeLink Expression Analysis v4.0 Software (GE). Complete transcription and hybridization were validated using bacterial sequences as external controls as well as housekeeping genes as internal controls. The raw data were normalized using the median value of the background. Normalized data were imported into Excel Software (Microsoft) and filtered based on flag calls. The ratio of increase or decrease of gene expression was calculated by dividing the normalized data of treated and control groups. Only genes with at least a 2-fold increase or decrease in expression were selected for further analysis. Statistical analysis was performed with the Significance Analysis of Microarray Program (SAM package [35] ). The genes significantly upregulated or downregulated by at least a factor of 2 were further analyzed with FatiGOþ software [36] to obtain functional profiles using Gene Ontology (GO) terms.
Data sets of unfiltered signal intensities were formatted according to the Minimum Information about Microarray Experiment database guidelines [37] and submitted to the ArrayExpress database [38] , where they can be accessed by the number E-MEXP-1497.
Northern Blotting Studies
The mRNA levels for matrix metalloproteinase 7 (Mmp7), osteopontin (Spp1), and neuronal pentraxin 1 (Nptx1) were measured by Northern blot using 32 P-labeled RT-PCR products as probes. Total RNA samples were used to obtain the cDNA first strand, using the ThermoScript cDNA RT-PCR System (Invitrogen, Carlsbad, CA). The resulting cDNA was used in PCRs with primers (Invitrogen) designed to amplify specific regions of the different cDNAs ( Table  1 ). The amplification of the Gapdh transcript was used as an internal control. The PCR mixture consisted of 2 ll cDNA, 1.5 mM MgCl 2 , 0.2 mM dinucleotide triphosphate, 0.5 lM of each primer, and 2.5 units of Taq DNA polymerase (Invitrogen) in a final reaction volume of 25 ll. Samples were amplified in an Applied Biosystems 9600 Fast Thermal cycler (Applied Biosystems, Foster City, CA). The thermal cycles were usually one denaturation cycle at 948C/5 min, 35 cycles at 948C/5 min, 608C/1 min, 728C/2 min, and an extension period at 728C for 7 min. The PCR products were resolved onto 1.5% agarose gel containing ethidium bromide (0.5 lg/ml) and visualized under UV transilumination. After extraction from the gel (gel extraction kit; QIAgen), the identity of each product was confirmed by direct nucleotide sequencing in an ABIPRISM 377 Automated Sequencer (Applied Biosystems) using the DYEnamic ET Terminator Sequencing kit (Amersham Biosciences). The PCR products were labeled with 32 P using the Random Primers DNA Labeling System (Invitrogen).
For the Northern blot analysis, 15 lg total RNA was separated on an agarose/ formaldehyde/MOPS gel. The separated RNAs were transferred by capillarity to a nitrocellulose membrane (Millipore, Bedford, MA) and crosslinked with UV light. Ultraviolet crosslinked membranes were prehybridized at 658C for 3 h in 63 standard saline citrate (SSC)/53 Denhardt solution, 0.5% SDS, and 100 lg/ ml sheared denatured salmon sperm DNA (Invitrogen). Hybridization was performed overnight at 658C in the same solution, but containing the 32 P-labeled probes (10 6 dpm/ml hybridization solution). The membranes were then washed three times for 15 min with 23 SSC/0.1% SDS at room temperature, and twice with 13 SSC/0.1% SDS at 658C. After exposure to film for autoradiography (BioMax MS film; Eastman Kodak Co., Rochester, NY), the membranes were washed twice, at 958C for 20 min with a stripping solution (0.13 SSC with 0.5% SDS), and rehybridized with the probe for Gapdh. After autoradiography, the bands corresponding to the expected size were submitted to densitometric analysis with Scion Image software (2000; Scion Corp., Frederick, MD) and normalized based on the intensity of the Gapdh-related product.
Light Microscopy Analysis
Tissue preparation. Animals were anesthetized with an intraperitoneal injection of sodium pentobarbital (40 mg/kg), and the efferent ductules were removed through an abdominal incision. The tissues were dissected, freed from fat, immersed in Bouin fixative for 16 h, dehydrated, and embedded in paraffin. Longitudinal sections of 5 lm were cut on a microtome and mounted on silanized glass slides.
Morphological and histochemical analysis. Efferent ductule sections were stained with Masson trichrome [40] or with Congo red [41] for identification of collagen or amyloid deposits, respectively. Congo red staining indirectly indicates the presence of pentraxin family members that are common constituents of amyloid deposits [42] [43] [44] .
The stained sections were visualized with a Nikon E800 microscope (Nikon, Melville, NY). Images were processed using a CoolSNAP-Pro CCD digital camera and Image-Pro Express Software Program (Media Cybernetics, Silver Spring, MD). Fifteen random microscope fields (4003 magnification) from each tissue section (three animals per group) were digitally captured under fixed microscope illumination settings and exposure times to ensure consistent image quality across all pictures. Stained areas were quantified using Adobe Photoshop 7.0 (Adobe Systems Inc., San Jose, CA). The color of interest (blue for collagen or red for amyloid deposits) was selected with the Color Range tool, keeping the Fuzziness option, which controls the tolerance to include related colors, fixed for all images. The stained areas were quantified with the Histogram tool of the software, which calculates the total number of pixels of selected stained areas and the number of pixels of the whole image. Results were expressed as the average percentage of collagen or amyloid deposits staining per total area analyzed.
Immunohistochemistry for MMP7. Immunoperoxidase staining of MMP7 was performed according to previously described protocols [45] [46] [47] . Briefly, tissue sections were incubated for 15 min at 378C with blocking solution (10% normal rabbit serum) in Tris-buffered saline (TBS; 20 mM Tris-HCl, 150 mM NaCl, 0.1% BSA, pH 7.4). Afterwards, they were incubated in a humidified chamber for 90 min at 378C with an affinity-purified goat polyclonal antibody raised against a C-terminal peptide of human MMP7 (Santa Cruz Biotechnol-FIG. 1. Two-dimensional scatterplot of the microarray analysis of the effects of ICI 182,780 on the efferent ductules from the rat. Each dot represents the average from three independent experiments (different RNAs) for the same gene in control (horizontal axis) and ICI 182,780-treated rats (vertical axis). Values represent the average of three independent analyses for each group. Gray dots represent genes with expression near to background or saturation; black dots represent genes that were used for further analysis. Genes that were expressed similarly in the experimental groups appear along the central diagonal (y ¼ x); genes differently expressed by the groups appear above or below this line. The two parallel lines mark the limits for 2-fold difference and separate 263 genes that were upregulated at least 2-fold and 98 genes that were downregulated at least 2-fold. 
Statistical Analysis
Data obtained from Northern blotting experiments, testosterone and estradiol determination, and quantification of collagen and amyloid deposits in rat efferent ductules were submitted to Student t-test statistical analysis. P , 0.05 was considered significant. Statistical analysis used for microarray results was described in Microarray Studies. 
RESULTS
Treatment
Effects of ICI 182,780 Treatment on Overall Gene Expression in the Efferent Ductules
A scatterplot summary of the microarray expression data in efferent ductules from control and ICI 182,780-treated rats, including all genes (33 849) represented on the CodeLink Rat Whole Genome Bioarray slide is shown in Figure 1 . As expected, variance was higher at low than at high expression levels. Figure 1 also indicates that the ICI 182,780 treatment altered the expression of a substantial number of genes. When the arbitrary difference of at least 2-fold change was selected, 263 genes were identified as significantly upregulated and 98 genes as significantly downregulated in efferent ductules from ICI 182,780-treated rats when compared to control (SAM package statistical analysis). The complete list of all genes that were Table S1 and Supplemental  Table S2 , respectively (available online at www.biolreprod.org). Tables 2 and 3 show the functional clustering according to GO classification [48] . Only those categories that contained at least two transcripts were included. The individual identity of genes upregulated or downregulated at least 5-fold after ICI 182,780 treatment is shown in Tables 4 and 5 , respectively. The surfactant associated protein D (Sftpd) and the epididymal glycoprotein (Aeg)/cysteine-rich secretory protein 1 (Crisp1) were the most altered genes (upregulated 26-and 22-fold, respectively). Crystallin was the most downregulated gene (15-fold). Several genes related to transport were also altered by the treatment: the expression of 42 genes was enhanced, and the expression of 20 genes was decreased. Among these genes, the sodium phosphate carrier (Slc34a2), the glycine carrier (Slc38a5), and the integral membrane transport protein (Ust5r) were, respectively, 18-, 9-, and 5-fold upregulated, whereas the zinc ion carrier (Slc30a2) was 11-fold downregulated.
Genes related to extracellular matrix (ECM) organization were particularly affected by the ICI 182,780 treatment. Genes that encode molecules of the ECM and related components are mainly present in the following GO categories: regulation of cell proliferation, cell adhesion, immune response, growth factor activity, cell-cell signaling, and apoptosis. Interestingly, most of the genes in these GO categories were upregulated (Table 2) . Table 6 shows the most altered genes related to ECM organization, including proteoglycans, adhesion proteins, actinrelated protein, growth factors, proteases, and immune response elements.
Treatment with ICI 182,780 Altered the Expression of Genes Related to ECM Organization
For validation of the microarray data in further analyses, three genes were selected based on the following characteristics: (1) high sensitivity to the antiestrogen treatment (at least 5-fold change); (2) a role in ECM organization; and (3) presence of estrogen response elements in the promoter region or presence of binding sites for other transcription factors known 436 to mediate estrogen action in target tissues such as AP-1 complex, transcription factor SP1, or nuclear factor NFKB (reviewed in Björnström and Sjöberg [32] ). The following three genes were then analyzed: matrix metalloproteinase 7 (Mmp7), osteopontin (Spp1), and neuronal pentraxin 1 (Nptx1). Northern blotting analysis confirmed that mRNA levels for Mmp7 and Spp1 were significantly increased (Fig. 2, A and B,  respectively) , and the mRNA levels for Nptx1 were significantly reduced (Fig. 2C) by the antiestrogen treatment.
Morphological and histochemical analysis of the efferent ductules from control and ICI 182,780-treated animals were performed. Control rats showed efferent ductules with narrow lumen, thick epithelium, tall epithelial cells, and tubules close to each other (Fig. 3, A and C) . Efferent ductules from ICI 182,780-treated rats showed dilated lumen, thinner epithelium, and altered ECM (Fig. 3, B and D) .
MMP7 has a broad range of substrate specificity, including digestion of collagen type 4 [49] . The increase in Mmp7 mRNA levels after the antiestrogen treatment was accompanied by reduction of collagen content in the space between the ductules (Fig. 3, A vs. B) , indicating that collagen-degrading activity is enhanced in treated animals. NPTX1 belongs to a family of proteins that are present in amyloid complexes [43] , and the histochemical analysis using Congo red revealed a decrease in the amount of amyloid complexes in extracellular space from efferent ductules of treated animals (Fig. 3, C vs. D) .
Treatment with ICI 182,780 Induced an Increase in MMP7 Expression in Rat Efferent Ductules
Under basal conditions, a discrete and diffuse expression of MMP7 was detected in epithelial cells of the efferent ductules (Fig. 4A ). The treatment with ICI 182,780 induced an increase in the total specific staining for MMP7, and a stronger increase was observed in the apical region of the epithelium and in the lumen. A faint and diffuse staining became apparent in the extracellular compartment (Fig. 4C) . No immunostaining was detected when the antibody was preadsorbed with the respective blocking peptide (Fig. 4, B and D) .
DISCUSSION
The main purpose of this study was to provide a more comprehensive analysis of the molecular targets involved in 
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estrogen action in the rat efferent ductules. The effects of ICI 182,780 on gene regulation were previously studied by Shayu et al. [50] in the epidydimis of the mouse, but to our knowledge this is the first microarray analysis of the effects of ICI 182,780 on the rat efferent ductules. The marked alteration on gene expression of the efferent ductules observed after ICI 182,780 treatment was not due to changes in testosterone and estradiol levels, since the antiestrogen treatment did not affect plasma or tissue levels of these hormones.
The effects of ICI 182,780 depend on the species studied, but blockade of fluid reabsorption and luminal dilation of the efferent ductules seem effects common to the species analyzed so far [15, [23] [24] [25] 51] . Therefore, our finding that ICI 182,780 altered expression of about 60 transport-related genes was not surprising, and it is an indication that the treatment was effective. One of the key factors causing fluid accumulation in rat efferent ductules after antiestrogen treatment is a reduction in AQP9 expression [28] . Our finding that Aqp9 mRNA was downregulated (4-fold) and that Aqp1 expression was upregulated (3-fold) is in accordance with previous observations that estrogen regulates the expression of these genes in opposite ways in efferent ductules [28] . We did not detect any changes on other aquaporins, although Shayu et al. [50] described that ICI 182,780 downregulated Aqp4 in the mouse epididymis. The upregulation of Cftr (3 times) is also in accordance with previous findings that estrogen regulates secretion of Cl À through CFTR, and that Cftr gene transcription is estrogen dependent [24, 52] .
The present study revealed several other genes related to transport that were highly sensitive to ICI 182,780 treatment and may constitute new targets to study mechanisms by which estrogen regulates fluid composition in the efferent ductules. Among these genes, the most affected were the sodium phosphate carrier Slc34a2, which facilitates transcellular inorganic phosphate flux in several tissues [53, 54] , the glycine carrier Slc38a5, the integral membrane transport protein Ust5r, and the zinc ion carrier Slc30a2.
The microarray analysis revealed several other genes related to organization and remodeling of the ECM that were also affected by treatment with ICI 182,780. Furthermore, morphological analysis showed that the treatment with the antiestrogen not only caused the expected dilation of the lumen and reduction of epithelium height, but also affected the extracellular compartment. These results suggest that estrogen may also be important for the maintenance of architecture and organization of the tissue, and this in turn may affect cell-cell interactions and the function of the tissue.
To validate the results obtained in the microarray, we further analyzed the effect of the ICI 182,780 treatment on expression of three of the most affected genes related to ECM organization: Mmp7 (14-fold upregulated), which encodes the MMP7, Spp1 (5-fold upregulated), which encodes the matrix glycoprotein osteopontin (SPP1), and Nptx1 (6-fold downregulated), which encodes the neuronal pentraxin 1 (NPTX1). Northern blot results confirmed that these three genes were strongly affected by the antiestrogen treatment and that Mmp7 was the most enhanced gene. It is worth mentioning that in the microarray analysis the mRNA levels for tissue inhibitors of metalloproteinases (Timp genes) were not affected by the antiestrogen treatment.
The specific role for MMP7 in the efferent ductule needs to be clarified. MMP7 presents a broad spectrum of actions [49] , and studies with MMP7-null mice have provided support for a physiological role for MMP7 during re-epithelialization, apoptosis, and tumorigenesis [55] [56] [57] . In the male reproductive tract, MMP7 is expressed in a variety of tissues and is present in human semen [58] [59] [60] . The importance of MMP7 for testicular integrity has been demonstrated by studies with transgenic animals overexpressing MMP7 [59] , which presented disintegration of the testicular interstitial tissue and infertility. In the rat prostate, MMP7 is localized to the secretory granules of epithelial cells, but bilateral orchidectomy induces a change in MMP7 localization to the stroma just below the epithelium, suggesting that MMP7 can participate in the remodeling of the epithelial-stroma interface, probably by degradating components of the epithelial basement membrane [61] .
In addition, MMP7 is one of the few members of the metalloproteinases family that is expressed in polarized epithelium [62] . Secretion of proteins to a particular compart- 438 ment in polarized epithelium can be cell type dependent [63] , and a cell-dependent secretion of MMP7 to the apical or to the basolateral compartment has already been described in kidney, lung, and colon epithelium [62] . In the efferent ductules, treatment with ICI 182,780 dramatically increased the expression of MMP7 in the apical region of the epithelium and in the lumen. MMP7 may have several potential functions in these compartments, including regulation of cell proliferation, which has been shown in MDCK kidney epithelial polarized cells [62] , release of growth factors and other proteins, cell apoptosis, and an action on spermatozoa, which appears compatible with the presence of MMP7 activity in human semen [60] .
Moreover, we also detected a faint immunostaining for MMP7 in the extracellular compartment, suggesting that it may also be released to the basolateral compartment. In fact, the collagen content in the extracellular compartment was reduced, and this might be a result of the increased activity of MMP7 in the extracellular compartment.
The increase in MMP7 expression in the efferent ductules induced by fulvestrant may appear surprising, because estrogen is known to increase MMP7 expression in the uterus [64, 65] . Mmp7 mRNA levels were also increased by the selective estrogen receptor modulators (SERMS) raloxifene and idoxifene, but raloxifene reduced Mmp14 expression [64, 65] . It is well known that SERMS can act as estrogen receptor agonists, partial agonists, or antagonists in a tissue-dependent manner [66] . An important finding of our study was that not only SERMs, but also the antagonist fulvestrant, may affect the expression of genes in the same way as estrogen. Although the effect of estrogen was completely abolished by ICI 182,780 in MCF-7 breast cancer cells [67] , this pattern may differ depending on the tissue. Clusters of genes responding to different antiestrogenic drugs in either antagonistic or agonistic fashion have been previously identified [68, 69] .
Matrix metalloproteases and other ECM-related genes play an important role in tumor cell invasion and cancer metastasis [49, 70, 71] . Fulvestrant is used in the treatment of breast carcinoma in postmenopausal women [72] , and increased expression of MMP7 obviously seems undesirable in these conditions. Our study underlines the importance of careful examination of the responses to this antiestrogen on gene expression in malignant cells. This kind of analysis has already been done in breast carcinoma cell lines [68, 69] .
The second gene analyzed, Spp1, also presents a broad spectrum of actions [73] and affects several physiological and pathological processes in the male reproductive tract. SPP1 is expressed in early germ cells from spermatogonia to early pachytene spermatocytes, and it probably aids adhesion of germ cells to the basement membrane and adjacent Sertoli cells [74] . In prostate cancer cells, SPP1 has been associated with cancer progression and metastasis [75] . In the rat epididymis, SPP1 presents a cell-and region-specific distribution. SPP1 in the epididymis is regulated by androgen [74] , may stimulate removal of calcium from the lumen, and reduces sperm fertility. In the rat efferent ductules, SPP1 is expressed in nonciliated cells and does not seem to be regulated by circulating androgen [74] . Our study suggests that estrogen is a candidate to regulate SPP1 expression in nonciliated cells of the efferent ductules.
Finally, we confirmed that the antiestrogen treatment strongly reduced the expression of neuronal pentraxin 1 (Nptx1) and decreased amyloid deposits in the efferent ductules. The function of amyloid complexes in the male reproductive tract is not known, but the incidence of these deposits in seminal vesicles increases with age, and it correlates with hemospermia [76] .
NPTX1 is a member of the pentraxins, a large family of proteins highly conserved during evolution (reviewed in Garlanda et al. [43] ). The presence of Nptx1 mRNA in the efferent ductules was unexpected, since NPTX1 was thought to be selectively expressed in the nervous system, where it may be involved in synaptic loss, neurite damage, and apoptotic neurotoxicity evoked by amyloid beta oligomers, and in the pathology of Alzheimer disease [44] . In the central nervous system, a decrease in estrogen levels stimulates the deposition of amyloid complexes and increases the incidence of Alzheimer disease [77, 78] . It remains to be investigated whether estrogen regulates the expression of Nptx1 in the central nervous system.
Although the physiological role of NPTX1 in the efferent ductules is unknown, this protein could possibly regulate reproductive processes, like other members of the pentraxin family (reviewed in Garlanda et al. [43] ). In the male reproductive tract, the presence of the pentraxin serum amyloid P component has been recently described in testis, seminal vesicle, spermatozoa and, to a lesser extent, in epididymis, vas deferens, and prostate [79] . A role for estrogen to regulate other pentraxins has already been demonstrated. Treatment of male hamsters with diethystilbestrol increases serum levels of the female protein FP and has been associated with enhanced amyloidosis [80] .
Pentraxins bind to many proteins, and they may act on both the hydrophilic and hydrophobic compartments of the cells because the water-soluble pentamer can reversibly dissociate into the lipid-soluble monomer [81] . Based on proposed functions of other pentraxins (see Garlanda et al. [43] for review), we speculate that NPTX1 could play several roles in the efferent ductules: First, it could be secreted to the lumen, bind to spermatozoa, and play a role in sperm-oocyte interactions. Second, it could be involved in cell degradation by binding to apoptotic cells and facilitating their capture by macrophages. Third, it could play a role in immunity, facilitating pathogen recognition by phagocytes. Fourth, it could be secreted into the ECM and contribute to its assembling and stabilization.
In summary, the three analyzed genes have in common a high sensitivity to estrogen, may play a role in the organization of the ECM, and may also be secreted to the luminal compartment to regulate sperm fertilizing capability.
In conclusion, antiestrogen treatment had a significant impact on gene expression in the rat efferent ductules. Some of these changes were expected and/or already known, but the present study revealed other potential targets in the efferent ductules, and opens up a wide field of investigation to help understand the regulatory role of estrogen in male reproductive tract.
